Morepen Laboratories Limited (BOM:500288)
42.22
-1.74 (-3.96%)
At close: May 27, 2026
Morepen Laboratories Revenue
In the fiscal year ending March 31, 2026, Morepen Laboratories had annual revenue of 18.27B INR with 0.85% growth. Morepen Laboratories had revenue of 4.93B in the quarter ending March 31, 2026, with 9.09% growth.
Revenue
18.27B
Revenue Growth
+0.85%
P/S Ratio
1.27
Revenue / Employee
10.07M
Employees
1,814
Market Cap
23.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 18.27B | 154.30M | 0.85% |
| Mar 31, 2025 | 18.12B | 1.21B | 7.17% |
| Mar 31, 2024 | 16.90B | 2.68B | 18.88% |
| Mar 31, 2023 | 14.22B | -1.34B | -8.60% |
| Mar 31, 2022 | 15.56B | 3.58B | 29.87% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Unichem Laboratories | 22.65B |
| Hikal | 17.46B |
| Gufic Biosciences | 8.97B |
| Bliss GVS Pharma | 8.68B |
| Venus Remedies | 7.03B |
| Lincoln Pharmaceuticals | 6.52B |
| Fredun Pharmaceuticals | 6.39B |
| Syncom Formulations (India) | 5.21B |
Morepen Laboratories News
- 7 days ago - Morepen Laboratories appoints Vipul Kumar Srivastava as Company Secretary - Business Upturn
- 4 weeks ago - Morepen Laboratories secures Rs 30 crore term loan from Shinhan Bank - Business Upturn
- 5 weeks ago - Morepen Labs gets US FDA clearance with 0 observations for Himachal unit, 4th straight nod with 0 observations - Business Upturn
- 2 months ago - Morepen Laboratories repays Rs 99 crore credit facility to Kotak Mahindra Bank - Business Upturn
- 3 months ago - Pharma sector stocks down today, March 2: Morepen Lab falls 3.24%, Ajanta Pharma drops 2.32%, Natco Pharma down 2.26% - Business Upturn
- 3 months ago - Morepen Laboratories shares surge nearly 15% today after Rs 825 crore global CDMO deal, up 30% in two days - Business Upturn
- 3 months ago - Pharma sector stocks today, Feb 23: Morepen Labs up 13.92%, Cohance Lifesciences jumps 4.37%, EMCURE Pharma down 3% - Business Upturn
- 3 months ago - Morepen Laboratories shares jump nearly 10% after Rs 825 crore global CDMO deal - Business Upturn